Skip to main navigation Skip to search Skip to main content

Development of ATP-allosteric bivalent inhibitors for targeting EGFR in non-small cell lung cancer

University at Buffalo

Project: Research

Project Details

StatusActive
Effective start/end date03/9/26 → 03/8/27

Funding

  • Empire Discovery Institute: $75,025.00